Inventor · disambiguated record
Yutaka Midorikawa
Also filed as: MIDORIKAWA YUTAKA
2 granted patents·7 pending applications·17 citations·filing 2003–2019
59Inventor score
Top patents by PatentIndex Score
9 records- 0185US9513292B2Method for diagnosing cancer by detecting GPC3PERSEUS PROTEOMICS INC·Filed 2014·Granted Dec 6, 2016·7 cites·5 claims
- 0278US7691586B2Method for predicting and judging the recurrence of liver cancer after treating liver cancerPERSEUS PROTEOMICS INC·Filed 2005·Granted Apr 6, 2010·10 cites·14 claims
- 0372US2020181248A1Antibody against secreted n-terminal peptide of gpc3 present in blood or c-terminal peptide of gpc3CHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 0468US2010183595A1Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3CHUGAI PHARMACEUTICAL CO LTD·Filed 2009·Application pending·0 cites
- 0563US2009060907A1Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3CHUGAI PHARMACEUTICAL CO LTD·Filed 2007·Application pending·0 cites
- 0662US2006167232A1Antibody against n-terminal peptide or c-terminal peptide of gpc3 solubilized in bloodCHUGAI PHARMACEUTICAL CO LTD·Filed 2003·Application pending·0 cites
- 0760US2006188510A1Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3CHUGAI PHARMACEUTICAL CO LTD·Filed 2006·Application pending·0 cites
- 0856US2017233462A1Antibody Against Secreted N-Terminal Peptide of GPC3 Present in Blood or C-Terminal Peptide of GPC3CHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 0945US2006014223A1Method for diagnosing cancer by detecting gpc3PERSEUS PROTEOMICS INC·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yutaka Midorikawa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →